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WE developed  an  in  vitro organ  bath  method  to
measure  permeability  and  contractility  simultane-
ously  in  murine  intestinal  segments.  To  investigate
whether permeability and contractility are correlated
and influenced by mucosal damage owing to inflam-
mation, BALB/c mice were exposed to a 10% dextran
sulphate sodium (DSS) solution for 8 days to induce
colitis.  The  effect  of  pharmacologically  induced
smooth muscle relaxation and contraction on perme-
ability  was  tested  in  vitro.  Regional  permeability
differences were observed in both control and 10%
DSS-treated  mice.  Distal  colon  segments  were  less
permeable to 3H-mannitol and 14C-PEG 400 molecules
compared with proximal colon and ileum. Intestinal
permeability  in  control  vs.  10%  DSS  mice  was  not
altered, although histologic inflammation score and
IFN-g pro-inflammatory  cytokine  levels  were  sig-
nificantly increased in proximal and distal colon. IL-
1b levels were enhanced in these proximal and distal
segments,  but  not  significantly  different  from  con-
trols.  Any effect  of  pharmacologically induced  con-
tractility  on  intestinal  permeability  could  not  be
observed. In conclusion, intestinal permeability and
contractility  are  not  correlated  in  this  model  of
experimentally  induced  colitis  in  mice.  Although
simultaneous measurement in a physiological set-up
is possible, this method has to be further validated.
Key  words:  permeability,  contractile  activity,  dextran
induced colitis, mannitol, polyethylene glycol 400, mice
Introduction
The  intestinal  epithelium  demonstrates  different
properties,  providing  both  barrier  and  transport
functions  to  luminal  molecules. A defective  barrier
function  may  contribute  to  changes  in  intestinal
permeability.  As  a  result  of  this  impaired  barrier
function, antigen access can initiate and perpetuate
inflammation.1 Moreover,  studies  in  animal  models
indicate a causal relationship between the presence
of mucosal inflammation and altered sensory-motor
function.2 In  human  inflammatory  bowel  disease
(IBD) alterations in intestinal permeability3 and motil-
ity2,4 are both reported. However, it remains unclear
whether these factors play an initiating role in the
pathogenesis of human IBD or are secondary results
of released inflammatory mediators.
In clinical practice and research, several intestinal
permeability tests are used. Monitoring urinary excre-
tion  of  orally  administered  test  markers  provides
information  on  the  intestinal  barrier  function.  Fre-
quently  used  markers  are  the  cylindrical  polymer
polyethylene  glycol  400  (PEG  400)5 with  a  cross-
sectional diameter of 5.3 Å, the globular shaped sugar
alcohol mannitol6 with a cross-sectional diameter of
6.7  Å  and  chromium-51-labelled  EDTA3,5–7 with  a
cross-sectional diameter of approximately 11 Å.8,9
Current in vitro animal studies of intestinal perme-
ability  use  flat  tissue  sheets,  mounted  in  Ussing
chambers,10 while contractility is studied in smooth
muscle strips immersed in organ baths.11 Intestinal
permeability  in  in  vivo animal  models  is  mostly
studied  in  perfused  intestinal  segments,12 giving  a
more physiological approach. However, operational
systems  to  study  intestinal  permeability  and  con-
tractility simultaneously in whole colonic segments,
including the mucosa, longitudinal and circular layers
and neuronal plexus are not available. Therefore our
aim was to develop an in vitro organ bath method to
measure  permeability  and  contractility  simultane-
ously in normal and inflamed intestinal segments of
mice. The degree of inflammation was determined by
macroscopic scoring, histology and measuring cyto-
kine levels in different intestinal segments.
Methods
Animals
Female BALB/c mice (20–22g, IFFA Credo, France)
were used in this study. They were kept individually
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under a 12-h day/night cycle at 20–22°C, and with a
relative humidity of 50% . Mice were permitted free
access  to  a  standard  mouse  chow  (Hope  Farms,
Woerden, The Netherlands) and DSS-supplemented or
normal tap water.
The experiments were carried out after approval of
the  Ethics  Committee  for  the  use  of  experimental
animals of the Rotterdam University Hospital (proto-
col 118–97–01).
Experimental design
Colitis  was  induced  by  adding  10%  (wt/vol)  DSS
(Mw>500 000, Pharmacia Biotech AB, Uppsala, Swe-
den) to the drinking water for 8 days. The control
group  received  normal  tap  water  throughout  the
study. At day 7 all animals were deprived from food
overnight and killed by cervical dislocation on day 8.
Prior to study initiation and before deprivation, body
weight was measured.
Drugs
Sodium nitroprusside (0.1 M) and carbachol (0.1M)
both from Sigma (St Louis, MO, USA) were dissolved
in distilled water and stored at 4°C until use.
Tissue preparation
Upon sacrifice, the intestines were removed from the
abdominal cavity. A segment of ileum most proximal
to  the  caecum  and  a  proximal  and  distal  colon
segment  were  taken  and  immediately  immersed in
standard Krebs buffer (pH 7.4) containing inmmol/l:
118NaCl, 4.7KCI, 2.5CaCI2. 2H 2O, 1.2MgSO4.7H 2O,
1.2KH2PO4, 25NaHCO3 and 8.3 glucose. Each seg-
ment  was  directly  cannulated  with  stainless-steel
cannulas,  mounted  horizontally  in  a  5ml  double-
walled perspex organ bath (Fig. 1). The organ baths,
warmed  to  37°C,  were  filled  with  standard  Krebs
buffer and continuously gassed with carbogen (95%
O2 and 5% CO2). The intestinal lumen was filled with
Krebs buffer containing marker molecules; 0.25m Ci/
ml 
3H-mannitol (NEN Life Science Products, Hoofd-
dorp, The  Netherlands),  with  a  specific  activity  of
22.4Ci/mmol  and  0.25m Ci/ml 
14C-PEG  400  (Amer-
sham  Life  Science,  ’s-Hertogenbosch,  The  Nether-
lands), with a specific activity of 0.135m Ci/mol. The
distal cannula was connected to a low pressure sensor
(D´ epex, De Bilt, The Netherlands), which measures
pressure differences between a passive port, set at
15mmHg  (registration  range:  ±10mmHg),  and  the
intraluminal pressure of the intestinal segment. The
signal  was  recorded  by  using  Multiple  Channel
Registration (MCR) computer-software.
Permeability measurement In vitro
Permeability measurement started at t=0 by replacing
the organ bath fluid with 5ml of fresh, carbogenated
Krebs buffer. Every subsequent 5min, 1ml samples
were  taken  from  the  serosal  reservoir  for  marker
analysis, directly followed by exchange of the entire
organ bath fluid. This procedure was continued for
55min. The samples were collected in 20ml Econo
glass  vials  (Packard  Instrument  BV ,  Groningen, The
Netherlands) and 7ml of scintillation fluid (Pico-Fluor
15; Packard Instrument BV , Groningen, The Nether-
lands) was added. Each vial was counted for radioac-
tivity  by  b liquid  scintillation  counting  (1500 TRI-
CARB  Liquid  Scintillation  Analyzer;  Packard
Instrument BV , The Netherlands).
Contractility measurement In vitro
Running  parallel  with  the  permeability  measure-
ments, contractile activity was monitored by measur-
ing intraluminal pressure (mmHg) in each segment. At
t=25, 30 and 35min, smooth muscle relaxation was
induced by adding a single dose of 50m l nitroprusside
(0.1M; final concentration 10–3M) to the organ bath
directly after buffer exchange. At t=40, 45 and 50min
smooth  muscle  contraction  was  induced  following
the  same  procedure  with  a  single  dose  of  50m l
carbachol (0.1M; final concentration 10–3M).
Macroscopy and histology
Upon sacrifice, the removed intestines were macro-
scopically  examined.  Signs  of  inflammation  were
scored. The  macroscopic  score  ranged  from  0–8,
which represents the sum of scores from 0 to 2 for
weight gain, appearance, diarrhoea and occult blood.
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FIG. 1. Schematic presentation of the in vitro model. The
intestinal  segment  (S)  is  cannulated  with  stainless-steel
cannulas (C) and mounted in a double-walled organ bath (O)
that contains carbogenated standard Krebs buffer at 37°C.
The  intestinal  lumen  is  filled  with  standard  Krebs  buffer
containing  marker  molecules  via  a  syringe.  The  distal
cannula  is  connected  to  a  low  pressure  sensor  (P). Con-
tractility is recorded as pressure difference compared to a
reference port and registered by Multiple Channel Registra-
tion computer-software.Specimens of proximal, middle and distal colon were
taken for histology. The sections were fixed in 3.6%
buffered formalin, pH 7, and embedded in paraffin
wax. Sections cut at 5-m m thickness, and stained with
haematoxylin and azafloxin were examined under a
light microscope using a 403 magnification. A colitis
activity  score  was  used to  score  each  section  in a
blind fashion based on the method of Dieleman et
al.13 and as detailed in Table 1. The total histological
activity score ranged from 0 to 9, which represents
the  sum  of  scores  from  0  to  3  for  inflammation,
damage/necrosis and regeneration.
Cytokine bioassays
Small  tissue  sections  of  proximal  and  distal  colon
were taken for determination of IFN-g , TNF-a and IL-
1b cytokine synthesis. After adding 1ml of standard
Krebs buffer, the tissue was homogenized for ± 10s
using  an  Ultra-Turrax  (Polytron,  Switzerland).  The
suspension was centrifuged (400 3 g, 10min, 4°C)
and  the  supernatant  was  stored  at  –20°C  until
analysis. The  cytokine  concentration  in  the  super-
natant  was  determined  by  means  of  ELISA  and
expressed in pg/mg tissue.
For  IFN-g ,  a  specific  mouse  IFN-g ELISA kit was
obtained from HyCult biotechnology BV (Uden, The
Netherlands).  Microplates  pre-coated  with  mono-
clonal antibody specific for mouse IFN-g were incu-
bated with 150m l sample or standard for 1h at 37°C.
After  three  washing  steps,  100m l  of  biotinylated
antibody reagent mixed with streptavidin conjugate
was  added.  Microplates  were  incubated  for  1h  at
37°C. After three times washing, 100m l para-nitrophe-
nyl-phosphate (PNPP) substrate solution was added to
the  wells.  Microplates  were  developed at  37°C  for
30min in the dark. To stop the enzymatic reaction
30m l NaOH (3M) was added. The optical density was
measured spectrophotometrically at 450nm using a
Microplate Reader (model 3550, Bio-Rad Laboratories,
Richmond, USA). The detection range was between
175 and 7000pg/ml. For the assay of TNF-a , a specific
mouse TNF-a ELISA kit  was  obtained  from  Biotrak
(Amersham Life Science, UK). Microplates pre-coated
with a solid phase monoclonal antibody specific for
mouse TNF-a were incubated with 50m l sample or
standard along with 50m l biotinylated antibody rea-
gent for 2h at room temperature. After washing five
times  to  remove  unbound  sample  proteins  and
biotinylated  antibody,  100m l  of  streptavidin  conju-
gated to horseradish peroxidase (HRP) was added to
the wells. Microplates were incubated for 30min at
room temperature and washed five times. Hereafter,
100m l  of  TMB  substrate  solution  was  added. The
microplates were developed at room temperature for
30min in the dark. To stop the enzymatic reaction
100m l sulphuric acid (0.18M) was added to the wells.
The  optical  density  of  each  well  was  determined
spectrophotometrically  by  using  the  Microplate
Reader at 450nm. The detection range was between
50 and 2450pg/ml.
IL-1b was determined by using a high sensitivity IL-
1b assay from Biotrak (Amersham Life Science, UK).
Microplates pre-coated with a solid phase monoclonal
antibody  specific  for  mouse  IL-1b were  incubated
with  50m l  sample  or  standard  along  with  50m l
biotinylated  antibody  reagent  for  2h  at  room  tem-
perature. After three washing steps, 100m l of strepta-
vidin-HRP  conjugate  was  added  to  the  wells. The
microplates  were  incubated  for  30min  at  room
temperature. After three washing steps, 100m l of TMB
substrate  solution  was  added.  Microplate  develop-
ment  and  measurement  was  similar  to  the TNF-a
assay. The  detection  range  was  between  15.6  and
1000pg/ml.
Statistical analysis
Data  are  presented  as  means  (SEM). The  statistical
significance of differences was determined by using
the  Mann–Whitney ranking  test. P <0.05 was  con-
sidered statistically significant.
Results
All mice developed a mild colitis after drinking 10%
DSS for 8 days. The macroscopic score for appear-
ance, diarrhoea, occult  blood and weight  gain was
significant  increased  (P <0.01)  in  10%  DSS-treated
animals  compared  with  controls  (Table  2).  Micro-
scopic examination of tissue from different intestinal
regions  showed  a  significantly  increased  score  (P
<0.05) in proximal and distal colon segments of 10%
DSS-treated animals versus controls.
The production of IFN-g in inflamed proximal and
distal colon tissue was significant increased (P <0.05)
compared  with  controls.  IL-1b levels  in  inflamed
Intestinal permeability and contractility
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Table 1. Histologic grading of colitis









3 Severe (transmural, involving
muscularis propria)
Regeneration 3 None
2 Focal migration and mitotic
features
1 Broad, multifocal re-
epithelialization
0 Complete re-epithelializationproximal  and  distal  colon  were  raised,  but  not
significantly different from controls (Table 3). TNF-a
levels were under detection limit in intestinal tissue of
both 10% DSS-treated and control animals (data not
shown).
Passage of the marker molecules, from the luminal
to the serosal side, was reproducible measured with
the  in  vitro organ  bath  method.  Figure  2  shows
representative  permeation  profiles  of  a  10%   DSS
treated (B) and control  (A) animal.  Regional  differ-
ences  in  permeability  were  observed.  Distal  colon
segments  were  less  permeable  to 
3H-mannitol  and
14C-PEG  400  molecules  compared  with  proximal
colon and ileum  in both  groups.  Exposure  to  10%
DSS-induced  enhanced  permeability  in  the  ileum
segment,  but  did  not  alter  permeability  in  the
inflamed proximal and distal  regions. The intestinal
segments  showed  a  higher  passage  of 
3H-mannitol
than  of 
14C-PEG  400  molecules  in  both  groups.
Simultaneously with permeability measurement, con-
tractile  activity  was  monitored  in  time  (Fig.  3).
Smooth muscle contraction is observed as an increase
of  intraluminal  pressure,  while  relaxation  of  the
smooth  muscles  was  reflected  by  a  decline  in
pressure. Periodic buffer exchange caused a revival of
smooth muscle activity in proximal and distal colon
segments, but this phenomenon was not observed in
the  ileum.  Ileum  intraluminal  pressure  diminished
during  the  experiments  possibly  due  to  the  large
relaxing properties of the smooth muscles in these
M.E. van Meeteren et al.
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Table 2. Experimentally induced colitis by 10% DSS administration to BALB/c mice. The degree of inflammation determined by
macroscopic scoring and histology for proximal, middle and distal colon segments of control (n= 5) and 10%  DSS treated mice
(n = 7)
Group Macroscopic score Microscopic score
Proximal Middle Distal
Control 0.4 (0.3) 4.0 (0.6) 3.0 (0.9) 3.4 (1.2)
10%  DSS 5.6 (0.6)* 6.4 (0.6)** 5.7 (0.7) 6.4 (0.5)**
*Significantly different (P < 0.05) from control. **Significantly different (P < 0.01) from control. Results are shown as mean score (SEM).
Table 3. Experimentally induced colitis by 10%  DSS administration to BALB/c mice. IFN-g and IL-1b levels in proximal, middle
and distal colon segments of control (n = 5) and 10%  DSS treated mice (n = 7)
Segment [IFN-g ] (pg/mg tissue)
Control 10%  DSS
[IL-1b ] (pg/mg tissue)
Control 10%  DSS
Proximal 2.7 (1.8) 27.2* (7.0) 0.2 (0.2) 1.5 (0.4)
Middle 1.7 (1.0) 12.5 (4.4) 3.7 (3.3) 2.1 (0.8)
Distal 0 37.2* (27.7) 2.0 (1.0) 2.4 (0.8)
*Significantly different (P < 0.05) from control. Results are shown as mean (SEM).
FIG. 2. Permeability monitored with 3H-mannitol (3H) and 14C-PEG 400 (14C) from luminal towards serosal side in different
intestinal segments of a control (A) and 10% DSS-treated mouse (B).segments. Serosal additions of sodium nitroprusside
induced a rapid decrease in smooth muscle activity,
while  repeated  addition of  carbachol  resulted  in  a
sustained smooth muscle contraction. Any effect  of
these  pharmacologically  induced  contractile  altera-
tions on changes in intestinal permeability could not
be observed.
Discussion
No  previous  studies  have  been  able  to  measure
permeability and contractility simultaneously in intes-
tinal segments. We developed a new in vitro organ
bath method in which reliable data were obtained in




cules, while smooth muscle contractility was online
monitored by registration of intraluminal pressure.
Okayasu  et  al.14 developed  a  new  experimental
model for ulcerative colitis in mice. In our hands the
applied animal model in which 10% DSS was admin-
istered via the drinking water to BALB/c mice for 8
days,  induced  a  reproducible  mild  colitis.  Macro-
scopic  signs  of  inflammation  were  reflected  by
diarrhoea,  occult  blood  and  loss  of  body  weight.
Contrary to the results of Okayasu et al.14 not only the
distal colon was affected, but also proximal colon was
significantly more inflamed in 10% DSS treated mice.
This may be caused by the difference in molecular
weight of the administered DSS. In the present study
dextran  with  a  molecular  weight  of  >500000  was
used, while in the experiments of Okayasu et al.14 a
dextran fraction with a molecular weight of 54000
was used to induce colitis.
After 8 days of 10%  DSS administration IFN-g pro-
inflammatory  cytokine  levels  were  significantly
increased in proximal and distal colon segments. IL-
1b levels were also raised in these sections, but not
significantly  different from  controls.  Besides, TNF-a
levels were undetectable in colonic tissue on day 8.
These results confirmed observations of van Dijk et
al.15 who found that IL-1b and TNF-a cytokines were
detectable at peak levels on day 2 in 10% DSS-treated
BALB/c mice and were subsequently downregulated
thereafter.
Despite the significant increased degree of inflam-
mation  in  proximal  and  distal  colon  segments,  no
difference in permeability to 3H-mannitol or 14C-PEG
400 molecules was observed. According to Hollander8
intestinal permeability of water-soluble compounds is
dependent on the specific size of the marker mole-
cules  based  on  the  hypothesis  of  tight  junctional
differences between intestinal villi and crypts. It was
proposed that smaller and more resistant tight junc-
tions at the tips of villi can be penetrated by smaller
compounds.  Larger  compounds  (around  10  Å)  can
only penetrate the crypt tight junctions where access
from the lumen is more limited. Mannitol and PEG
400 are permeability markers of nearly equal size (6.7
and  5.3  Å  respectively). The  permeation  route  of
mannitol is proposed to be paracellular. The pathway
of PEG 400 is not so clearly defined and is possibly
paracellular and/or transcellular.9 Our results showed
nearly identical permeation profiles for both marker
molecules. Mannitol crossed the intestinal barrier in
slightly  larger  amounts  compared  with  PEG  400,
Intestinal permeability and contractility
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FIG. 3. Contractility, simultaneously measured with permeability (see Fig. 2) and serosal influenced by nitroprusside (NP) and
carbachol (C) at various time points.resulting in mannitol/PEG 400 permeation ratios »  1.3
(data not shown). To discriminate between the two
proposed tight junctional permeability routes, man-
nitol or PEG 400 and a larger marker molecule should
be used in forthcoming experiments.
In  addition,  no  effect  of  the  pharmacological
altered intraluminal pressure was seen on the permea-
tion  profiles.  Sodium  nitroprusside,  a  nitric  oxide-
donor inducing smooth muscle relaxation via cellular
increased  cGMP  levels  and  carbachol  known  as  a
muscarinic agonist inducing smooth muscle contrac-
tion were possibly not able to alter intestinal permea-
bility. Other pathways, like 5-HT3 receptor agonists,
triggering the fast opening of cation selective chan-
nels to induce contraction and for instance salbuta-
mol  as  a  selective  b 2-receptor  agonist  inducing
relaxation should be investigated.
In summary, we developed a new operational in
vitro organ  bath  method  in  which  simultaneous
measurement  of  intestinal  permeability  and  con-
tractility  in a physiological set-up is possible. How-
ever,  despite  the  significantly  enhanced  degree  of
intestinal inflammation, altered permeability and con-
tractility was not demonstrated, nor correlated in this
model  of  experimentally  induced  colitis  in  mice.
Further validation of this method is recommended.
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